
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 92.800 | 92.800 | 0.000 |
Bonds | 7.200 | 7.200 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.675 | 17.079 |
Price to Book | 3.727 | 2.415 |
Price to Sales | 3.095 | 1.981 |
Price to Cash Flow | 16.143 | 9.496 |
Dividend Yield | 1.065 | 2.992 |
5 Years Earnings Growth | 9.245 | 10.885 |
Name | Net % | Category Average |
---|---|---|
Technology | 53.830 | 22.488 |
Healthcare | 19.250 | 10.733 |
Industrials | 17.840 | 13.318 |
Consumer Cyclical | 4.340 | 12.560 |
Communication Services | 3.770 | 9.694 |
Consumer Defensive | 0.970 | 10.746 |
Energy | 0.010 | 3.417 |
Number of long holdings: 64
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alphabet Inc Class C | - | 3.47 | - | - | |
Keyence | JP3236200006 | 3.42 | 56,820.0 | +1.41% | |
Intuitive Surgical Inc | - | 3.42 | - | - | |
Amazon.com Inc | - | 3.25 | - | - | |
International Business Machines Corporation 3.62% | - | 2.98 | - | - | |
Apple Inc. 2.4% | - | 2.95 | - | - | |
PTC Inc | - | 2.85 | - | - | |
Qualcomm Inc | - | 2.61 | - | - | |
Ansys Inc | - | 2.61 | - | - | |
Thermo Fisher Scientific Inc | - | 2.54 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Actinver Portafolio Tactico 1 B | 4.32B | 41.00 | 4.17 | 11.16 | ||
Actinver Portafolio Tactico 3 A | 4.3B | -7.94 | 10.19 | 7.69 | ||
Actinver Portafolio Tactico 3 B | 4.3B | -8.92 | 7.35 | 4.91 | ||
Actinver Portafolio Tactico 3 E | 4.3B | -8.88 | 7.44 | 5.04 | ||
Actinver Portafolio Tactico 1 A | 2.07M | -3.75 | 7.67 | 10.95 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review